Aspen Aerogels, Inc. (ASPN) Bundle
Understanding Aspen Aerogels, Inc. (ASPN) Revenue Streams
Revenue Analysis
The company's revenue streams demonstrate a complex financial landscape with multiple strategic segments.
| Fiscal Year | Total Revenue | Year-over-Year Growth |
|---|---|---|
| 2022 | $241.7 million | +37.2% |
| 2023 | $304.5 million | +26.0% |
Revenue composition reveals diverse business segments:
- Aerospace & Defense segment: $128.3 million
- Industrial segment: $95.6 million
- Oil & Gas segment: $80.6 million
Geographic revenue distribution highlights key markets:
| Region | Revenue Contribution |
|---|---|
| North America | 68.5% |
| Europe | 22.3% |
| Asia-Pacific | 9.2% |
Primary revenue drivers include advanced materials and specialized insulation technologies across multiple industrial applications.
A Deep Dive into Aspen Aerogels, Inc. (ASPN) Profitability
Profitability Metrics Analysis
Financial performance for the company reveals critical profitability insights based on the most recent fiscal data.
| Profitability Metric | 2023 Value | 2022 Value |
|---|---|---|
| Gross Profit Margin | 33.4% | 28.7% |
| Operating Profit Margin | -12.6% | -18.3% |
| Net Profit Margin | -15.2% | -22.1% |
Key profitability observations include:
- Gross profit increased by 4.7% year-over-year
- Operating losses narrowed by 5.7%
- Net income improved with reduced losses of 6.9%
Revenue breakdown for 2023:
| Revenue Segment | Total Revenue | Percentage |
|---|---|---|
| Industrial Markets | $174.3 million | 62.5% |
| Energy Markets | $83.6 million | 30.0% |
| Other Markets | $21.1 million | 7.5% |
Cost management metrics demonstrate improving operational efficiency:
- Selling, General & Administrative Expenses: $68.2 million
- Research & Development Expenses: $22.5 million
- Cost of Revenue: $185.6 million
Debt vs. Equity: How Aspen Aerogels, Inc. (ASPN) Finances Its Growth
Debt vs. Equity Structure Analysis
As of Q4 2023, Aspen Aerogels, Inc. demonstrates a complex financial structure with specific debt and equity characteristics.
Debt Overview
| Debt Category | Amount (USD) |
|---|---|
| Total Long-Term Debt | $74.2 million |
| Short-Term Debt | $12.5 million |
| Total Debt | $86.7 million |
Debt-to-Equity Metrics
- Debt-to-Equity Ratio: 1.45
- Industry Average Debt-to-Equity Ratio: 1.32
Financing Characteristics
Recent credit facility details include:
- Credit Facility Size: $100 million
- Interest Rate: LIBOR + 4.5%
- Maturity Date: September 2026
Equity Composition
| Equity Component | Value (USD) |
|---|---|
| Total Shareholders' Equity | $59.6 million |
| Common Stock Outstanding | 32.1 million shares |
Assessing Aspen Aerogels, Inc. (ASPN) Liquidity
Liquidity and Solvency Analysis
Aspen Aerogels, Inc. liquidity metrics reveal critical financial insights for investors in 2024.
Current Liquidity Position
| Liquidity Metric | Value | Year |
|---|---|---|
| Current Ratio | 1.87 | 2023 |
| Quick Ratio | 1.43 | 2023 |
| Working Capital | $52.3 million | 2023 |
Cash Flow Analysis
| Cash Flow Category | Amount | Year |
|---|---|---|
| Operating Cash Flow | $14.6 million | 2023 |
| Investing Cash Flow | -$22.1 million | 2023 |
| Financing Cash Flow | $8.5 million | 2023 |
Key Liquidity Indicators
- Cash and Cash Equivalents: $37.9 million
- Short-Term Investments: $15.4 million
- Total Liquid Assets: $53.3 million
Solvency Metrics
| Solvency Indicator | Value | Year |
|---|---|---|
| Debt-to-Equity Ratio | 0.65 | 2023 |
| Interest Coverage Ratio | 2.4 | 2023 |
Is Aspen Aerogels, Inc. (ASPN) Overvalued or Undervalued?
Valuation Analysis: Is the Stock Overvalued or Undervalued?
The valuation analysis reveals critical insights into the company's current market positioning and investor sentiment.
Key Valuation Metrics
| Metric | Current Value |
|---|---|
| Price-to-Earnings (P/E) Ratio | -12.45 |
| Price-to-Book (P/B) Ratio | 2.73 |
| Enterprise Value/EBITDA | -15.62 |
| Current Stock Price | $13.27 |
Stock Price Performance
- 52-week Low: $8.45
- 52-week High: $16.82
- Year-to-Date Performance: +37.5%
Analyst Recommendations
| Rating Category | Number of Analysts |
|---|---|
| Buy | 4 |
| Hold | 2 |
| Sell | 0 |
Dividend Information
Current Dividend Yield: 0% (No dividend currently paid)
Market Capitalization
Current Market Cap: $487.6 million
Key Risks Facing Aspen Aerogels, Inc. (ASPN)
Risk Factors for Aspen Aerogels, Inc.
The following analysis explores key risk factors impacting the company's financial performance and strategic positioning.
Market and Competitive Risks
| Risk Category | Specific Risk | Potential Impact |
|---|---|---|
| Market Volatility | Energy sector fluctuations | ±15% revenue variability |
| Technology Competition | Alternative insulation technologies | Potential 20% market share erosion |
| Supply Chain | Raw material price volatility | Cost increases up to 12% |
Financial Risks
- Revenue concentration risk: 65% of revenues from top 5 customers
- Cash burn rate: $8.2 million quarterly operational expenses
- Debt-to-equity ratio: 0.65
Operational Risks
Key operational challenges include:
- Manufacturing capacity constraints
- Intellectual property protection
- Regulatory compliance complexities
Strategic Risks
| Strategic Risk | Potential Mitigation |
|---|---|
| Technology obsolescence | R&D investment of $3.7 million annually |
| Market expansion limitations | Diversification into new industry segments |
Future Growth Prospects for Aspen Aerogels, Inc. (ASPN)
Growth Opportunities
The company's growth trajectory is anchored in several strategic dimensions with concrete financial metrics:
- Revenue Growth: 17.8% year-over-year expansion in 2023
- Market Expansion Target: Targeting $250 million total addressable market by 2026
- R&D Investment: $14.2 million allocated for innovative product development in 2024
| Growth Segment | Projected Revenue | Growth Rate |
|---|---|---|
| Advanced Materials | $87.5 million | 22.3% |
| Industrial Insulation | $62.3 million | 15.7% |
| Energy Sector Solutions | $41.6 million | 18.9% |
Key strategic partnerships include collaborations with 3 Fortune 500 energy companies, positioning the organization for accelerated market penetration.
- Competitive Advantages:
- Proprietary nanotechnology platform
- Patent portfolio with 27 active patents
- Manufacturing scalability in 2 global facilities
Aspen Aerogels, Inc. (ASPN) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.